Dimitrios Chaniotis Selected Research

Cytochrome P-450 CYP1A2 (CYP1A2)

1/2022

CYP1A2 polymorphisms modify the association of habitual coffee consumption with appetite, macronutrient intake, and body mass index: results from an observational cohort and a cross-over randomized study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Dimitrios Chaniotis Research Topics

Disease

3	Breast Neoplasms (Breast Cancer) 11/2022 - 10/2021
3	Neoplasms (Cancer) 01/2022 - 03/2018
1	Cardiovascular Diseases (Cardiovascular Disease) 03/2023
1	Schizophrenia (Dementia Praecox) 01/2023
1	Infections 01/2023
1	COVID-19 09/2022
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2022
1	Genetic Risk Score 01/2022
1	Obesity 01/2022
1	Colorectal Neoplasms (Colorectal Cancer) 03/2018
1	Hemorrhage 01/2017

Drug/Important Bio-Agent (IBA)

1	CytokinesIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 11/2022
1	TNF Receptor-Associated Factor 3IBA 11/2022
1	Coloring Agents (Dyes)IBA 01/2022
1	Caffeine (No Doz)FDA LinkGeneric 01/2022
1	Coffee FDA Link 01/2022
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 01/2022
1	LipofuscinIBA 01/2022
1	Tyrosine Kinase InhibitorsIBA 10/2021
1	Erlotinib Hydrochloride (CP 358,774)FDA Link 10/2021
1	Gefitinib (Iressa)FDA Link 10/2021
1	A-factor (Streptomyces)IBA 03/2018
1	Calcibiotic Root Canal SealerIBA 03/2018
1	Indicators and Reagents (Reagents)IBA 03/2018
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2017
1	TicagrelorIBA 01/2017
1	Prasugrel Hydrochloride FDA Link 01/2017

Therapy/Procedure

1	Renal Dialysis (Hemodialysis) 03/2023
1	Mediterranean Diet 09/2022
1	Therapeutics 01/2022